NEW STUDY LAUNCHED TO TEST STEM CELLS FOR KNEE PAIN

By Bilioine Young

Progenza, a stem cell product made by Regeneus LTD, will be the subject of a clinical trial designed to determine the safety, tolerability and preliminary efficacy of intra-articular Progenza in adults with symptomatic knee osteoarthritis.

An independent Human Research Ethics Committee registered with the Australian Government’s National Health and Medical Research Council approved of the trial. It will also be registered on the Australian New Zealand Clinical Trials Registry and notified to the Therapeutic Goods Administration through the Clinical Trials Notification Scheme.

Advertisement

Progenza is produced from adipose tissue from a healthy donor who has been extensively screened. Company officials claim that adipose tissue is readily available from donors in large quantities and has significantly higher mesenchymal stem cells (MSCs) per gram of tissue than other tissue sources such as bone marrow or cord tissue.

READ MORE HERE

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement